Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02169193

Diagnosis of Microaspiration in Intubated Critically Ill Patients: Pepsin vs 99m Technetium

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Microaspiration of contaminated oropharyngeal secretions and gastric contents frequently occurs in intubated critically ill patients, and plays a major role in the pathogenesis of ventilator-associated pneumonia. Quantitative pepsin measurement in tracheal aspirates would be useful in diagnosing microaspiration of gastric contents in intubated critically ill patients. Technetium 99m labelled enteral feeding is the gold standard for the diagnosis of microaspiration. The investigators hypothesized that tracheal pepsin measurement is a good diagnosis marker of microaspiration compared to the gold standard.

Detailed description

Microaspiration of contaminated oropharyngeal secretions and gastric contents frequently occurs in intubated critically ill patients, and plays a major role in the pathogenesis of ventilator-associated pneumonia Quantitative pepsin measurement in tracheal aspirates would be useful in diagnosing microaspiration of gastric contents in intubated critically ill patients Technetium 99m labelled enteral feeding is the gold standard for the diagnosis of microaspiration. We hypothesized that tracheal pepsin measurement is a good diagnosis marker of microaspiration compared to the gold standard

Conditions

Interventions

TypeNameDescription
RADIATION99mTc-Rhenium Sulfide Nanocolloid12 MBq of NanoCis added to 500 ml of enteral feeding

Timeline

Start date
2015-09-01
Primary completion
2016-09-01
Completion
2017-01-01
First posted
2014-06-23
Last updated
2015-12-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02169193. Inclusion in this directory is not an endorsement.